Immunowake Funding & Investors
Birmingham, AL
Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies. Immunotherapy involves harnessing the bodyβs immune system to identify and kill cancer cells in the same way pathogens are identified and targeted. Recent breakthroughs in cancer immunotherapy have demonstrated that powerful anti-tumor responses can be achieved by activating antigen-specific T-cells.
immunowake.comTotal Amount Raised: $23,000,000
Immunowake Funding Rounds
Series A
$20,000,000
Series A Investors
Hyfinity InvestmentsSouth China Venture CapitalHEDA VenturesLapam CapitalSeed
$3,000,000
Funding info provided by Diffbot.